Dr. Ankit Sakhuja, MD

Dr. Sakhuja practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Sakhuja's NPI, 1114182706, was assigned on July 23, 2008. Dr. Sakhuja graduated from All India Institute of Medical Sciences in 2007. Dr. Sakhuja holds New York license 324544.

Dr. Sakhuja's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Sakhuja also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Sakhuja's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Sakhuja to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sakhuja practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sakhuja's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Sakhuja's licenses on file in 4 states: New York, Michigan, Minnesota and West Virginia.

CMS data shows 186 Medicare services from Dr. Sakhuja across 1 procedure code in 2024, for 74 Medicare patients. Medicare paid $35,940 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 74 Medicare patients who saw Dr. Sakhuja in 2024. The largest group is 75 to 84, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sakhuja's median patient age at 62, with 45% women.

In 2017, Dr. Sakhuja wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $143 in total drug cost. In 2016, CMS named 237 claims across 9 drugs.

Dr. Sakhuja accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Sakhuja, published from 2023 to 2025. 2025 was the busiest year, with 9. The most frequent topics are Acute Kidney Injury, Intensive Care Units and Critical Care. Dr. Sakhuja has published most often in medRxiv. Dr. Sakhuja's most frequent co-authors are Roopa Kohli-Seth, MD, Girish Nitin Nadkarni, MD and Lili Chan, MD.

CMS Open Payments shows 5 general payments to Dr. Sakhuja from 4 drug and device companies from 2020 to 2024. Food and beverage make up the largest share, 89% of the total. Relypsa, Inc. paid the most, $222.

Dr. Sakhuja graduated from All India Institute of Medical Sciences in 2007.